NCT06426615

Brief Summary

The CONSCIUS study is a prospective, interventional study including patients with acute brain injury and impaired consciousness implanted with intracranial electrodes. The aim of the study is to investigate seizures and thalamocortical neural dynamics underlying behavioral unresponsiveness.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
20mo left

Started Jan 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress59%
Jan 2024Dec 2027

Study Start

First participant enrolled

January 1, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 29, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 23, 2024

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

May 23, 2024

Status Verified

March 1, 2024

Enrollment Period

4 years

First QC Date

March 29, 2024

Last Update Submit

May 17, 2024

Conditions

Keywords

ConsciousnessSeizuresNeural dynamicsIntracranial recordings and stimulation

Outcome Measures

Primary Outcomes (1)

  • Incidence of electrographic epileptiform activity (ictal and ictal-interictal continuum activity) on intracranial versus scalp electroencephalography (EEG).

    The primary aim is to compare the incidence of ictal and ictal-interictal continuum epileptiform activity on intracranial versus scalp EEG.

    A maximum of 4 weeks after electrode implantation.

Secondary Outcomes (3)

  • Correlating neural activity patterns (local field potentials and complexity) with behavioral responsiveness (measured using the Coma Recovery Scale-Revised).

    A maximum of 4 weeks after electrode implantation.

  • Acute effects of electrical stimulation on behavioral responsiveness (measured using the Coma Recovery Scale-Revised).

    During electrical stimulation trials, performed in the first 4 weeks after electrode implantation.

  • Correlation of neural activity profiles with long-term outcome (Coma Recovery Scale-Revised and Glasgow Outcome Scale-Extended)

    At 6 months and 1 year follow-up.

Study Arms (1)

Acute brain injury

EXPERIMENTAL

Patients with acute brain injury with reduced consciousness that undergo multimodal intracranial monitoring, or with suspected seizures

Device: Intracranial electrodes

Interventions

Placement of intracranial electrodes in the cortico-subcortical system

Also known as: Depth electrodes
Acute brain injury

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old or older
  • Brain injury of any kind, with impaired consciousness or suspected seizures

You may not qualify if:

  • \< 18 years old
  • Known pregnancy
  • Any condition that, in the judgement of the investigator, makes participation in the study unsafe or unfeasible (e.g., irreversible coagulopathy, large intracranial tumors, surgical technical problems…)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UZLeuven

Leuven, Vlaams-Brabant, 3000, Belgium

RECRUITING

MeSH Terms

Conditions

Brain InjuriesBrain Injuries, TraumaticConsciousness DisordersSeizures

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental Disorders

Study Officials

  • Tom Theys, MD PhD

    Universitaire Ziekenhuizen KU Leuven

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Prospective inclusion of patients implanted with intracranial electrodes.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 29, 2024

First Posted

May 23, 2024

Study Start

January 1, 2024

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

May 23, 2024

Record last verified: 2024-03

Locations